# K232417: MR Q; MR Q Supine; MR Q SLT

- Pathway: 510(k) (Traditional)
- Applicant: Meridian AG
- Decided: Jan 25, 2024 after 167 days
- Product code: HQF (Laser, Ophthalmic)
- Device class: 2
- Regulation: 21 CFR 886.4390
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
No later device cites it as a predicate yet.
0 of 1 device in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. FDA’s file for it is a 510(k) statement, which names no predicate.

## Indications for use
The MR Q and the MR SUPINE are intended to perform: - Posterior capsulotomy - Iridotomy The MR Q SLT in YAG mode is intended to perform: - Posterior capsulotomy - Iridotomy The MR Q SLT in SLT mode is intended to perform: - Selective laser trabeculoplasty

Source page: https://510kreport.com/device/K232417
Methodology: https://510kreport.com/methodology
